Tue, Feb 6, 2024 1:17 AM
Technical Breakout Stocks: How to trade them on 6th February 2024?
A Flip by Shubhangi Gupta
Concord Drugs reported Q2 2024 results with a 60.4% increase in net sales to Rs 11.84 crore, but a 89.71% decline in net profit to Rs 0.05 crore, and a 47.71% decrease in EBITDA to Rs 0.80 crore, resulting in a decreased EPS of Rs 0.05. Concord Drugs shares closed at 36.00 on November 25, 2024, with -5.11% returns over the last 6 months.
Open Flip
Reported Standalone quarterly numbers for Shukra Pharmaceuticals are: Net Sales at Rs 5.56 crore in September 2024 down 77.45% from Rs. 24.64 crore in September 2023. Quarterly Net Profit at Rs. 0.54 crore in September 2024 down 88.56% from Rs. 4.71 crore in September 2023. EBITDA stands at Rs. 1.69 crore in September 2024 down 68.29% from Rs. 5.33 crore in September 2023.
Open Flip
Reported Standalone quarterly numbers for Ortin Global are: Net Sales at Rs 0.05 crore in September 2024 down 78.9% from Rs. 0.26 crore in September 2023. Quarterly Net Loss at Rs. 0.47 crore in September 2024 up 57.85% from Rs. 1.12 crore in September 2023. EBITDA stands negative at Rs. 0.46 crore in September 2024 up 48.89% from Rs. 0.90 crore in September 2023.
Open Flip
